Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
30 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
Current reports
8-K
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
28 Mar 24
8-K
Other Events
9 Jan 24
8-K
Other Events
5 Oct 23
8-K
Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
15 Sep 23
8-K
Submission of Matters to a Vote of Security Holders
21 Aug 23
8-K
Other Events
16 Aug 23
8-K
Other Events
6 Jun 23
8-K
Other Events
28 Feb 23
8-K
Hoth Therapeutics Announces $10 Million Private Placement
30 Dec 22
8-K
Departure of Directors or Certain Officers
13 Dec 22
Registration and prospectus
424B3
Prospectus supplement
22 Apr 24
S-1
IPO registration
11 Apr 24
424B3
Prospectus supplement
28 Mar 24
424B5
Prospectus supplement for primary offering
14 Sep 23
S-8
Registration of securities for employees
21 Aug 23
S-3
Shelf registration
13 Jun 23
424B3
Prospectus supplement
26 Jan 23
S-3
Shelf registration
13 Jan 23
D
$10.00 mm in equity / options / securities to be acquired, sold $10.00 mm, 1 investor
4 Jan 23
S-8
Registration of securities for employees
1 Jul 22
Proxies
DEFA14A
Additional proxy soliciting materials
27 Jun 23
DEF 14A
Definitive proxy
27 Jun 23
DEFA14A
Additional proxy soliciting materials
14 Nov 22
DEF 14A
Definitive proxy
14 Nov 22
PRE 14A
Preliminary proxy
3 Nov 22
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
PRE 14A
Preliminary proxy
4 Apr 22
DEFR14A
Revised proxy
7 May 21
DEF 14A
Definitive proxy
7 May 21
Other
EFFECT
Notice of effectiveness
22 Apr 24
EFFECT
Notice of effectiveness
20 Jun 23
CORRESP
Correspondence with SEC
15 Jun 23
UPLOAD
Letter from SEC
15 Jun 23
EFFECT
Notice of effectiveness
26 Jan 23
CORRESP
Correspondence with SEC
23 Jan 23
UPLOAD
Letter from SEC
23 Jan 23
UPLOAD
Letter from SEC
4 Jan 23
CORRESP
Correspondence with SEC
3 Jan 23
UPLOAD
Letter from SEC
7 Dec 22